Unlike their medtech and bipharma counterparts, early-stage healthcare technology companies have marketable products. But their lack of marketing savvy is holding them back.
VIVO Agency and Boston Scientific’s collaboration on CVForward, a content marketing campaign, was shortlisted for an MM&M Award–Use of Relationship Marketing. Winners will be announced on October 10th, 2019 at MM&M’s annual 2019 Awards event.
VIVO Agency’s 2018 was defined by the larger transformation of healthcare technology. And because the agency’s presence in the sector — it specializes in devices, diagnostics and health IT products — it is very much along for the ride.
MM&M has announced the shortlist for awards scheduled to be presented at “A Night Out with MM&M,” the inaugural event celebrating the brand’s annual Agency 100 issue. VIVO Agency has been named a finalist for the “MedTech Medalist” award. This distinction goes to the agency whose client roster is stacked with the deepest mix of accounts in the medical device sector, from chronic or acute care to diagnostics.
PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Mike Nuckols as one of the 2019 PM360 ELITE 100. Now in its fifth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. Mike is one of only three Creative Directors named among the ELITE 100.
Marc Iskowitz and Larry Dobrow interview Tom Dudnyk about why he started his own agency and discuss the Transforming Healthcare conference panel about the future of value-based reimbursement.
The biggest story that is not being told is that HealthTech companies are transforming themselves in ways that more closely resemble wholesale reinvention. From product development, to sales and organizational models, more internally focused disruption is taking place than ever before.
Manufacturers should work to fill gaps in their portfolios to master disease management rather than focusing solely on one particular device category.
Healthcare providers have resisted the call to lead the value-based care movement. In 2019, the energy they are expending to resist change gets replaced by the energy to lead it. Why? They realize that the medical disciplines and business models that support them are no longer financially viable. The result?
To predict how 2019 could unfold, MD+DI looked back over 2018’s progress. MD+DI checked in with a few healthcare and medtech experts for their perspectives.
